000			01504 a2200397 4500
005			20250517133835.0
264		0	_c20170829
008			201708s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2017.01.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aMendoza-Rodríguez, Mónica
245	0	0	_aIL-1β induces up-regulation of BIRC3, a gene involved in chemoresistance to doxorubicin in breast cancer cells. _h[electronic resource]
260			_bCancer letters _c04 2017
300			_a39-44 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aBaculoviral IAP Repeat-Containing 3 Protein
650	0	4	_aBlotting, Western
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInhibitor of Apoptosis Proteins _xgenetics
650	0	4	_aInterleukin-1beta _xmetabolism
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aUbiquitin-Protein Ligases _xgenetics
650	0	4	_aUp-Regulation _xdrug effects
700	1		_aArévalo Romero, Haruki
700	1		_aFuentes-Pananá, Ezequiel M
700	1		_aAyala-Sumuano, Jorge-Tonatiuh
700	1		_aMeza, Isaura
773	0		_tCancer letters _gvol. 390 _gp. 39-44
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2017.01.005 _zAvailable from publisher's website
999			_c26790023 _d26790023